{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:04:54Z","timestamp":1791860694768,"version":"4.3.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.pcad.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:20:48Z","timestamp":1708514448000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial"],"prefix":"10.1016","volume":"85","author":[{"given":"Est\u00edbaliz","family":"D\u00edaz-Balboa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pe\u00f1a-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Rodr\u00edguez-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio I.","family":"Cuesta-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Lado-Baleato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amparo","family":"Mart\u00ednez-Monzon\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagros","family":"Pedreira-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Palacios-Ozores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"L\u00f3pez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Gonz\u00e1lez-Salvado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pcad.2024.02.002_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.seminoncol.2020.05.004","article-title":"Breast cancer survivorship","volume":"47","author":"Moore","year":"2020","journal-title":"Semin. Oncol."},{"issue":"1","key":"10.1016\/j.pcad.2024.02.002_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for practice guidelines","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.pcad.2024.02.002_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pcad.2022.10.005","article-title":"Determinants of oxygen utilization in breast cancer: similarities between heart failure with preserved ejection fraction","volume":"74","author":"Haykowsky","year":"2022","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"2","key":"10.1016\/j.pcad.2024.02.002_bb0025","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pcad.2019.02.002","article-title":"Curing breast cancer and killing the heart: a novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer","volume":"62","author":"Kirkham","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"41","key":"10.1016\/j.pcad.2024.02.002_bb0030","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.pcad.2024.02.002_bb0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.rec.2017.01.004","article-title":"Emerging cardiac imaging modalities for the early detection of cardiotoxicity due to anticancer therapies","volume":"70","author":"L\u00f3pez-Fern\u00e1ndez","year":"2017","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"10","key":"10.1016\/j.pcad.2024.02.002_bb0040","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.pcad.2024.02.002_bb0045","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ. Cardio. Imag."},{"key":"10.1016\/j.pcad.2024.02.002_bb0050","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2021.11.001","article-title":"Impact of cardiorespiratory fitness on outcomes in cardiac rehabilitation","volume":"70","author":"Tutor","year":"2022","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"11","key":"10.1016\/j.pcad.2024.02.002_bb0055","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.117.024671","article-title":"Exercise therapy and cardiovascular toxicity in Cancer","volume":"137","author":"Scott","year":"2018","journal-title":"Circulation."},{"issue":"4","key":"10.1016\/j.pcad.2024.02.002_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an international cardio-oncology society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.pcad.2024.02.002_bb0065","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1161\/CIR.0000000000000679","article-title":"Cardio-oncology rehabilitation to manage cardiovascular outcomes in Cancer patients and survivors: a scientific statement from the American Heart Association","volume":"139","author":"Gilchrist","year":"2019","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.pcad.2024.02.002_bb0070","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/2047487320913379","article-title":"Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology","volume":"28","author":"Ambrosetti","year":"2020","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"3","key":"10.1016\/j.pcad.2024.02.002_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/eurjpc\/zwab006","article-title":"The role of exercise in the prevention of cancer therapy-related cardiac dysfunction in breast cancer patients undergoing chemotherapy: systematic review","volume":"29","author":"Murray","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"18","key":"10.1016\/j.pcad.2024.02.002_bb0080","first-page":"8336","article-title":"Effects of exercise on cardiac function outcomes in women receiving anthracycline or trastuzumab treatment for breast cancer: a systematic review and meta-analysis","volume":"11","author":"Antunes","year":"2021","journal-title":"App. Sci. (Switzerland)"},{"issue":"12","key":"10.1016\/j.pcad.2024.02.002_bb0085","doi-asserted-by":"crossref","first-page":"10323","DOI":"10.1007\/s00520-022-07368-w","article-title":"Effect of aerobic exercise on cardiotoxic outcomes in women with breast cancer undergoing anthracycline or trastuzumab treatment: a systematic review and meta-analysis","volume":"30","author":"Ma","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.pcad.2024.02.002_bb0090","article-title":"Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracycline: a randomized controlled trial","volume":"28","author":"Antunes","year":"2023","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"1","key":"10.1016\/j.pcad.2024.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-021-01970-2","article-title":"A randomized trial to evaluate the impact of exercise-based cardiac rehabilitation for the prevention of chemotherapy-induced cardiotoxicity in patients with breast cancer: ONCORE study protocol","volume":"21","author":"D\u00edaz-Balboa","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"issue":"3","key":"10.1016\/j.pcad.2024.02.002_bb0100","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1997.15.3.974","article-title":"Reliability and validity of the functional assessment of cancer therapy- breast quality-of-life instrument","volume":"15","author":"Brady","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.pcad.2024.02.002_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0163-8343(03)00043-4","article-title":"A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population","volume":"25","author":"Herrero","year":"2003","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"3","key":"10.1016\/j.pcad.2024.02.002_bb0110","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s11764-015-0430-6","article-title":"Validation of the Godin-Shephard leisure-time physical activity questionnaire classification coding system using accelerometer assessment among breast cancer survivors","volume":"9","author":"Amireault","year":"2015","journal-title":"J. Cancer Surviv."},{"issue":"8","key":"10.1016\/j.pcad.2024.02.002_bb0115","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.numecd.2005.08.006","article-title":"Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk","volume":"16","author":"Panagiotakos","year":"2006","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"7","key":"10.1016\/j.pcad.2024.02.002_bb0120","first-page":"267","article-title":"Estimaci\u00f3n del tama\u00f1o de la muestra en la investigaci\u00f3n cl\u00ednica y epidemiol\u00f3gica","volume":"111","author":"Marrugat","year":"1998","journal-title":"Med. Clin. (Barc.)"},{"issue":"5","key":"10.1016\/j.pcad.2024.02.002_bb0125","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/jcm9051379","article-title":"The Preventive Role of Regular Physical Training in Ventricular Remodeling, Serum Cardiac Markers, and Exercise Performance Changes in Breast Cancer in Women Undergoing Trastuzumab Therapy\u2014An REH-HER Study","volume":"9","author":"Hojan","year":"2020","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.pcad.2024.02.002_bb0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCULATIONAHA.122.062814","article-title":"Exercise for the prevention of anthracycline-induced functional disability and cardiac dysfunction: the BREXIT study","volume":"147","author":"Foulkes","year":"2023","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.pcad.2024.02.002_bb0135","first-page":"100424","article-title":"TITAN trial: a randomized controlled trial of a cardiac rehabilitation care model in breast cancer","volume":"2","author":"Kirkham","year":"2023","journal-title":"JACC: Advances"},{"issue":"17","key":"10.1016\/j.pcad.2024.02.002_bb0140","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Article risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.pcad.2024.02.002_bb0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pcad.2018.08.006","article-title":"Meta-analysis of exercise training on left ventricular ejection fraction in heart failure with reduced ejection fraction: a 10-year update","volume":"62","author":"Tucker","year":"2019","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.pcad.2024.02.002_bb0150","article-title":"Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial","volume":"21","author":"Scott","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pcad.2024.02.002_bb0155","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pcad.2022.02.001","article-title":"Exercise training in cardiac rehabilitation: setting the right intensity for optimal benefit","volume":"70","author":"Sabbahi","year":"2022","journal-title":"Prog. Cardiovasc. Dis."},{"issue":"18","key":"10.1016\/j.pcad.2024.02.002_bb0160","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","article-title":"Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry","volume":"41","author":"L\u00f3pez-Send\u00f3n","year":"2020","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.pcad.2024.02.002_bb0165","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1503\/cmaj.051073","article-title":"Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis","volume":"175","author":"McNeely","year":"2006","journal-title":"CMAJ."},{"issue":"8","key":"10.1016\/j.pcad.2024.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/oby.2009.18","article-title":"Exercise improves body fat, lean mass, and bone mass in breast Cancer survivors","volume":"17","author":"Irwin","year":"2009","journal-title":"Obesity."},{"key":"10.1016\/j.pcad.2024.02.002_bb0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12916-015-0362-z","article-title":"Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial","volume":"13","author":"Travier","year":"2015","journal-title":"BMC Med."},{"issue":"15","key":"10.1016\/j.pcad.2024.02.002_bb0180","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1158\/1078-0432.CCR-09-0628","article-title":"Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training","volume":"15","author":"Haykowsky","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.pcad.2024.02.002_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/0284186X.2013.781673","article-title":"Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial","volume":"53","author":"Hornsby","year":"2014","journal-title":"Acta Oncol."},{"issue":"1","key":"10.1016\/j.pcad.2024.02.002_bb0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13063-019-3499-9","article-title":"Impact of exercise training on cardiotoxicity and cardiac health outcomes in women with breast cancer anthracycline chemotherapy: a study protocol for a randomized controlled trial","volume":"20","author":"Antunes","year":"2019","journal-title":"Trials."},{"key":"10.1016\/j.pcad.2024.02.002_bb0195","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.3389\/fcvm.2022.1000846","article-title":"Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab","volume":"9","author":"Jacquinot","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"Supplement_1","key":"10.1016\/j.pcad.2024.02.002_bb0200","article-title":"Impact of a cardio-oncology rehabilitation framework among high cardiovascular risk cancer survivors: results from the CORE trial. Eur","volume":"30","author":"Viamonte","year":"2023","journal-title":"J. Prev. Cardiol."},{"issue":"11","key":"10.1016\/j.pcad.2024.02.002_bb0205","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1007\/s00520-021-06294-7","article-title":"Effect of high-intensity interval training on patient-reported outcomes and physical function in women with breast cancer receiving anthracycline-based chemotherapy","volume":"29","author":"Lee","year":"2021","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.pcad.2024.02.002_bb0210","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00520-021-06470-9","article-title":"Design and implementation of a standard care programme of therapeutic exercise and education for breast cancer survivors","volume":"30","author":"Rold\u00e1n-Jim\u00e9nez","year":"2022","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.pcad.2024.02.002_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/pmrj.12731","article-title":"Factors associated with upper limb function in breast cancer survivors","volume":"15","author":"Rold\u00e1n-Jim\u00e9nez","year":"2023","journal-title":"PM R"},{"issue":"11","key":"10.1016\/j.pcad.2024.02.002_bb0220","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1249\/MSS.0000000000002116","article-title":"Exercise guidelines for Cancer survivors: consensus statement from international multidisciplinary roundtable","volume":"51","author":"Campbell","year":"2019","journal-title":"Med. Sci. Sports Exerc."},{"issue":"3","key":"10.1016\/j.pcad.2024.02.002_bb0225","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/2047487318811181","article-title":"Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients","volume":"26","author":"Howden","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.pcad.2024.02.002_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9965583","article-title":"A cardiac rehabilitation program for breast Cancer survivors: a feasibility study","volume":"2021","author":"Zvinovski","year":"2021","journal-title":"J Oncol"},{"issue":"3","key":"10.1016\/j.pcad.2024.02.002_bb0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamacardio.2019.5586","article-title":"Long-term cardiopulmonary consequences of treatment-induced cardiotoxicity in survivors of ERBB2-positive breast Cancer","volume":"5","author":"Yu","year":"2020","journal-title":"JAMA Cardiol."}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062024000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T16:29:23Z","timestamp":1729268963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062024000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":46,"alternative-id":["S0033062024000239"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2024.02.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exercise-based cardio-oncology rehabilitation for cardiotoxicity prevention during breast cancer chemotherapy: The ONCORE randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}